Compound Detail
CHEMBL491473
CEDIRANIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL491473 |
| Name | CEDIRANIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | XXJWYDDUDKYVKI-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
98
Targets
227
Activities
4
Assay Types
0
PK Parameters
20
Publications
5
Known Names
20
Indications
3
Mechanisms
Molecular Properties
450.5
MW (Da)
5.22
ALogP
6
HBA
1
HBD
72.5
PSA (Ų)
0.37
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Stem cell growth factor receptor inhibitor | INHIBITOR | Mast/stem cell growth factor receptor Kit | ✓ | ✓ |
| Platelet-derived growth factor receptor inhibitor | INHIBITOR | Platelet-derived growth factor receptor | ✓ | ✓ |
| Vascular endothelial growth factor receptor inhibitor | INHIBITOR | Vascular endothelial growth factor receptor | ✓ | ✓ |
Indications
Glioblastoma Neoplasms Neoplasms Ovarian Neoplasms Ovarian Neoplasms Biliary Tract Neoplasms Breast Neoplasms Breast Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Colorectal Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Sarcoma, Alveolar Soft Part Small Cell Lung Carcinoma Uterine Cervical Neoplasms Brain Neoplasms Endometrial Neoplasms Fallopian Tube Neoplasms
ATC Classification
L01EK02
cediranib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
Kd 132 meas. best 9.57
IC50 55 meas. best 9.3
Ki 39 meas. best 9.3
EC50 1 meas. best 4.54
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38088921 | 10.1021/acs.jmedchem.3c01054 | ClpP1P2 | 35 |
| 38088921 | 10.1021/acs.jmedchem.3c01054 | Unchecked | 19 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Unchecked | 9 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 29624387 | 10.1021/acs.jmedchem.8b00035 | Unchecked | 4 |
| 22037378 | 10.1038/nbt.1990 | Hepatocyte growth factor receptor | 3 |
| 38088921 | 10.1021/acs.jmedchem.3c01054 | Mycolicibacterium smegmatis | 3 |
| 22037378 | 10.1038/nbt.1990 | Ribosomal protein S6 kinase alpha-6 | 2 |
| 22037378 | 10.1038/nbt.1990 | Ribosomal protein S6 kinase alpha-5 | 2 |
| 22037378 | 10.1038/nbt.1990 | Leucine-rich repeat serine/threonine-protein kinase 2 | 2 |
| 22037378 | 10.1038/nbt.1990 | Non-receptor tyrosine-protein kinase TYK2 | 2 |
| 22037378 | 10.1038/nbt.1990 | Serine/threonine-protein kinase B-raf | 2 |
| 22037378 | 10.1038/nbt.1990 | Cyclin-dependent kinase 4 | 2 |
Data from ChEMBL 36 via Core Engine